Login / Signup

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial.

Simke W WaijerSieta T de VriesRobert BuschDi XieRon T GansevoortFan Fan HouJose Luis Gorriz TeruelGozewijn D LavermanLuca De NicolaJulio PascualMichele ProvenzanoPablo E PergolaSydney Chi-Wai TangChristoph WannerPhilippe ZaouiHans-Henrik ParvingDick de ZeeuwHiddo J L Heerspink
Published in: Journal of the American Society of Nephrology : JASN (2021)
Keyphrases
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • small cell lung cancer
  • epidermal growth factor receptor
  • case report
  • tyrosine kinase
  • open label
  • double blind
  • health insurance
  • randomized controlled trial